Oncology Pipeline 2024: Innovation and Trends

Pricing: Free for Members and Non-Members

Course Description

The oncology pipeline has continually expanded over the past decade, currently representing 38% of the agents in active development. Global spending on cancer medicine was $196 billion in 2022 and is expected to exceed $375 billion by 2027. As the number of treatments and the amount spent continue to increase, it is important for stakeholders to be aware of the latest therapies that will impact their practice. This session will cover key agents recently approved by the FDA or in late-stage development, focusing on novel mechanisms of action. The potential impact on current standards of care and what this may mean for payers will be discussed.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Identify recently approved and upcoming approvals of high-impact oncology specialty drugs for solid and hematologic malignancies.
  2. Differentiate the mechanisms of action, indications, safety, and efficacy of newly approved and emerging oncology specialty medications.
  3. Assess the impact of new and emerging approvals of oncology specialty medications on cost considerations, contracting, benefit formularies, and other managed care processes.

Commercial Support

This activity is supported by an independent medical education grant from Coherus Biosciences, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Replimune Group, Inc.

Course summary
Available credit: 
  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion
Course opens: 
11/11/2024
Course expires: 
12/31/2025
Cost:
$0.00

Kaelyn C. Boss, PharmD

Clinical Consultant Pharmacist
ForHealth Consulting University of Massachusetts Chan Medical School - Shrewsbury, MA
Shrewsbury, MA

Sita Bhatt, PharmD, BCOP

Clinical Pharmacy Specialist
Boston Medical Center
Boston, MA

Disclosures

Faculty/Reviewer/Planner​

Reported Relevant Financial Relationships​

Sita Bhatt, PharmD, BCOP​

Faculty​

Disclosed no relevant financial relationships.​

Kaelyn C. Boss, PharmD​

Faculty​

Disclosed no relevant financial relationships.​

Casey Koch​

Reviewer​

Disclosed no relevant financial relationships.​

Jennifer Evans​

Planner​

Disclosed no relevant financial relationships.​

​

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN: 0233-0000-24-063-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: November 11, 2024 •  Expiration Date: December 31, 2025
Activity Fee: Free for Members and Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

Available Credit

  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion

Price

Cost:
$0.00
Please login or register to take this course.